- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 207/416 - 2,5-Pyrrolidine-diones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
Patent holdings for IPC class C07D 207/416
Total number of patents in this class: 195
10-year publication summary
|
14
|
7
|
20
|
12
|
19
|
9
|
13
|
14
|
10
|
11
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Purdue Research Foundation | 3583 |
22 |
| Uniwersytet Jagiellonski | 261 |
10 |
| Warszawski Uniwersytet Medyczny | 63 |
10 |
| Dainippon Sumitomo Pharma Co., Ltd. | 195 |
9 |
| Otsuka Pharmaceutical Factory, Inc. | 297 |
7 |
| The Regents of the University of California | 19868 |
6 |
| The Boeing Company | 20042 |
5 |
| Coloplast A/S | 1896 |
5 |
| Bayer Pharma AG | 1061 |
4 |
| JSR Corporation | 2515 |
4 |
| Adabio Co.,Ltd. | 6 |
4 |
| Kyowa Hakko Bio Co., Ltd. | 309 |
3 |
| Rensselaer Polytechnic Institute | 821 |
3 |
| University of Maryland, Baltimore | 1015 |
3 |
| The University of North Carolina at Chapel Hill | 2029 |
3 |
| Correvio Canada Corp. | 18 |
3 |
| Correvio International Sàrl | 22 |
3 |
| UCL Business Ltd | 595 |
3 |
| Design Therapeutics Inc. | 46 |
3 |
| Bayer AG | 3327 |
2 |
| Other owners | 83 |